Uveitis Treatment Market Growth, Size, Analysis, Outlook

Uveitis Treatment Market

The Global Uveitis Treatment Market is valued at USD 703.54 Million in 2022 and is projected to reach a value of USD 958.91 Million by 2030, growing at a CAGR of 5.32% over the forecast period 2022- 2030.

Uveitis is considered a type of infection that causes inflammation of the eye. It typically affects the middle layers of eye wall tissue called the uvea.

Some of the common symptoms related to this condition include pain, redness, swelling, blurred vision, sensitivity to light, as well as floating dark spots in the field of vision.

Most cases of uveitis can be treated with antivirals, antibiotics, and steroids along with anti-inflammatory eye drops. It can also take at least 2 to 5 weeks for this condition to clear up, while in severe cases, recovery can take months.

The growing ubiquity of the disease, rising healthcare expenditures globally, and increasing R&D activities in the field are driving the market growth over the forecast period.

Additionally, the growing focus of drug manufacturers on developing and launching effective drugs in the field has created lucrative opportunities for the market to flourish.

Main market trends
Each market has its growth determinants and challenges. One of the major factors fueling the growth of the market over the forecast period is the growing geriatric population.

Also, the elderly population is very susceptible to eye disorders, such as uveitis. This is fueled by the fact that aging people have weakened immune systems and therefore easily catch viral infections.

Thus, a wide range of treatment options are being prescribed for the elderly with this disease and have driven the growth of the market over the forecast period.

Additionally, there has been an increasing ubiquity of eye conditions around the world. This is attributed to the deterioration of the immune system of the masses due to unhealthy lifestyle habits.

Also, increasing pollution levels and increasing geriatric population lead to an increase in the number of people with ophthalmic disorders. These factors have boosted the growth of the market over the forecast period.

Get a free sample report: https://wemarketresearch.com/sample-request/uveitis-treatment-market/401/

Market segment analysis

Based on type of treatment
• Corticosteroids
• Immunosuppressant
• Monoclonal antibodies
• Cycloplegic agents
• Antibiotics
• Antiviral
• Antifungal
• Analgesics
The corticosteroids segment is poised to rack up notable gains over the stipulated period owing to the effectiveness of these drugs in reducing inflammation in patients with uveitis.

Based on disease type
• Anterior uveitis
• Posterior uveitis
• Intermediate uveitis
• Panuveitis
The anterior uveitis segment is expected to generate significant returns over the estimated duration due to its increasing ubiquity among young adults.

• Infectious
• Non-infectious
The infectious segment is expected to grow significantly by 2030 due to the severity of infectious uveitis.

Based on distribution channel
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies
The online pharmacy segment is expected to account for a high volume share over the span of the analysis, credited to their advantageous features such as home delivery and discount offers.
North America is expected to expand at a considerable CAGR

The global uveitis treatment market is segmented into 4 major regions, namely North America, Europe, Asia-Pacific, Middle East and Africa. Among these, North America led the market growth over the forecast period. This is due to the increasing prevalence of autoimmune diseases, the increase in the geriatric population and the increase in healthcare expenditures around the world.

For more details, visit our report page: https://wemarketresearch.com/reports/uveitis-treatment-market/401/

Competitive landscape
Some of the major companies operating in the market are Allergan; Inc.; Bausch & Lomb Incorporated; Santen Pharmaceutical Co.; Ltd; AbbVie Inc.; Novartis SA; Eyegate Pharmaceuticals; Inc.; Regeneron Pharmaceuticals; Eyepoint Pharmaceuticals Inc.; and Alimera Sciences; Inc.

Frequently Asked Questions
• What is the growth rate of the global uveitis treatment market?
• What are the main determinants of market growth?
• What are the major regions that make up the geographic landscape of the market?
• What are the main companies operating in the market?

Contact us:
We study the market
Phone: +1(650)-666-4592
Email: [email protected]
The Web: https://wemarketresearch.com/

About We Market Research:
WE MARKET RESEARCH is an established market analysis and research company with domain experience spanning different industries. We have worked on multi-county market research since our inception. Over time since our existence, we have won accolades for our deep-rooted market research and insightful analysis of various markets.
Our strategic market analysis and ability to understand the deep cultural, conceptual and social aspects of various entangled markets has helped us stand out in the industry. WE MARKET RESEARCH is a pioneer in supporting many companies; both regionally and internationally to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of designing market strategies that ensure guaranteed customer bases for our clients.

This press release was published on openPR.

Comments are closed.